Medal of Freedom to be given to Inouye
HONOLULU - The late U.S. Sen. Daniel Inouye will be among 16 recipients of the Presidential Medal of Freedom to be presented by President Barack Obama this week.
The White House said the president will bestow the nation's highest civilian honor to this year's recipient at a ceremony Wednesday. The recipients include former President Bill Clinton and Oprah Winfrey.
Inouye, who died last year at the age of 88, will receive his posthumously.
Inouye was a World War II hero who became the first Japanese American to serve in Congress, representing the people of Hawaii from the moment they joined the Union.
Kauai hospitals' emergency funding OK'd
HONOLULU - The state Senate is approving more than $7 million in emergency funding for Kauai's publicly funded hospitals and clinics.
Lawmakers passed the legislation recently during a special session called to consider a measure on same-sex marriage.
The measure now goes to the governor for approval.
A Senate news release says emergency funding will ensure that the facilities that make up Hawaii Health Systems Corp.'s Kauai region remain operational through the spring of 2014. Those facilities include Kauai Veterans Memorial Hospital, Samuel Mahelona Memorial Hospital and three clinics.
State to receive $1.4M in drug settlement
HONOLULU - Drug giant Johnson & Johnson is paying Hawaii $1.4 million as part of a multibillion-dollar national settlement over allegations it illegally promoted two of its best-selling anti-psychotics drugs.
Hawaii Attorney General David Louie announced the settlement with Johnson & Johnson subsidiary Janssen Pharmaceuticals earlier this month.
He said the total settlement for Hawaii is about $2.9 million, with most of it going to the federal government, which pays for the majority of Hawaii's Medicaid program.
The Justice Department alleged that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.
Louie said that in addition to the monetary sanctions, Janssen Pharmaceuticals will plead guilty in federal court to misbranding for its illegal marketing of the drugs.